Eurofins Viracor’s three new blood assays look fast, but can they change transplant monitoring?
Eurofins Viracor adds rapid CXCL9, CXCL10 and IL-18 plasma assays, but clinical utility, logistics and reimbursement will shape adoption.
Medical Devices & Diagnostics
Pharma & Biotech
Sepsis breakthrough? What the EMBRACE trial reveals about Sobi’s emapalumab strategy
Swedish Orphan Biovitrum AB (Sobi) has reported positive topline data from the Phase 2a EMBRACE trial of Gamifant (emapalumab) in interferon-gamma-driven sepsis (IDS), demonstrating organ function improvement and a potential survival benefit. Based on the signal, the drug will advance in development in collaboration with the Hellenic Institute for the Study of Sepsis (HISS). The